MedTrace Logo

Distinguishing Patient Groups Using Autonomic Dysfunction

NCT04964921 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-11-03

No results posted yet for this study

Summary

A study population with impaired fasting glucose levels, impaired glucose tolerance levels and diabetes (with or without complications) along with healthy patients will be chosen as participants. Their vital signs and their ECG (electrocardiograph) will be recorded during their only visit. Data analysis will be performed using the vital signs parameters. The RR intervals from the ECG will be analyzed by 5 different techniques to determine the best technique that stratifies the subjects the most accurately.

Conditions

Interventions

OTHER

Device: ANSiScope Plus

Heart rate variability measurement and vital signs monitoring will be performed on all subjects.

Sponsors & Collaborators

  • DyAnsys, Inc.

    lead INDUSTRY

Principal Investigators

  • Dr. Bathula Sridhar, MD,DM (Endo) · Samraksha Diabetes, Thyroid, Endocrine Superspecialty Hospital and Research Centre

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2022-02-28
Completion
2022-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04964921 on ClinicalTrials.gov